#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Henoch-Schonlein purpura Fms-like tyrosine kinase 3 positive Alveolar rhabdomyosarcoma Glycogen storage disease type V Thrombotic thrombocytopenic purpura Aicardi-Goutieres syndrome Bile acid synthesis disorder Heart disease congenital Arteriosclerosis Raynaud's phenomenon Mitochondrial myopathy Small cell lung cancer limited stage Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Immune-mediated enterocolitis Pancreatic carcinoma More trials…

    Learn about Rare Diseases

    Mucopolysaccharidosis III – Diagnostics Medulloblastoma recurrent – Basic Information Glomerulonephritis rapidly progressive – Treatment Skin angiosarcoma – Basic Information Richter’s syndrome – Trials in Disease Mucopolysaccharidosis I – Treatment Angiosarcoma recurrent Proteus syndrome – Trials in Disease Malignant fibrous histiocytoma – Treatment Haemophilia A without inhibitors – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ivosidenib Izaflortaucipir (18F) Ergocalciferol Bp Savolitinib Posenacaftor Atomoxetine Mps-106 LTI-03 Tenofovir Alafenamide Losmapimod AZD3632 Telmisartan Benzylpenicillin Sodium Rbl012.2 Minzasolmin Elexacaftor Nms-03305293 Exemestane Fluoxetine Hydrochloride Poa Pratensis More therapies…

    Learn about Your Condition

    Nasal sinus cancer Cancer fatigue Pulmonary vascular disorder Hepatic adenoma Tourette's disorder T-cell lymphoma Uterine leiomyoma Oesophageal atresia Post-traumatic stress disorder Cholestatic pruritus Uterine cancer Arteriovenous graft thrombosis Rectal neoplasm Synovial sarcoma recurrent Altered state of consciousness More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Mental Disorders

  • Study on Brain Inflammation in Schizophrenia Patients Using 18F-DPA-714

    Recruiting

    4 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • N,N-Diethyl-2-(2-(4-(2[(18)F]-Fluoroethoxy)Phenyl)5,7Dimethylpyrazolo[1,5A]Pyrimidin-3-Yl)Acetamide
    France

  • Study on the Effects of Escitalopram and Bupropion on Dopamine Levels in Patients with Major Depression

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Escitalopram Oxalate
    • Bupropion Hydrochloride
    Austria

  • Title: Study of Hydrocortisone Treatment to Improve Fear Response in Adults with Post-Traumatic Stress Disorder (PTSD) and Hormonal System Changes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Post-traumatic stress disorder
    Investigated Drugs:
    • Hydrocortisone
    The Netherlands

  • Study of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants

    Recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • (1S)-1-[4-[3-[4-(6-FLUORO-1,2-BENZOXAZOL-3-YL)PIPERIDIN-1-YL]PROPOXY]-3-METHOXYPHENYL]ETHANOL
    Bulgaria Czechia Germany Poland

  • Study on ITI-1284 for Treating Psychosis in Alzheimer’s Patients

    Recruiting

    2 1
    Investigated Diseases:
    • Psychotic disorder
    • Dementia of the Alzheimer’s type with delusions
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Iti-1284
    Bulgaria Croatia Czechia Italy Poland Romania +2

  • Study of Light Therapy and Melatonin for Treatment of Major Depressive Episode with Insomnia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Insomnia
    • Depression
    Investigated Drugs:
    • Melatonin
    France
Previous Page
1 … 6 7 8 9 10 … 40
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!